bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • CytomX Therapeutics Inc. logo

    CytomX Therapeutics Inc.

    CTMX | NASDAQ
    Chart Builder DCF Calculator
    $2.76
    $0 (0.00%)
    At close: Sep 21, 2026, 4:00 PM ET
    $2.75
    -$0.01 (-0.36%)
    Pre-market: Sep 22, 2026, 5:01 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $600.86M
    Enterprise Value
    $276.28M
    Beta
    2.14
    Average Volume
    3.78M
    Shares Outstanding (Diluted)
    218.94M
    Shares Change YoY
    69.62%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US23284F1057

    Price Performance

    Price Change 1M
    -17.1%
    Price Change 3M
    -12.4%
    Price Change 6M
    -34.6%
    Price Change YTD
    -35.1%
    Price Change 1Y
    34.0%
    Price Change 3Y
    115.6%
    Price Change 5Y
    -47.5%
    1M CAGR (ann.)
    -18.1%
    1Y CAGR (ann.)
    43.0%
    5Y CAGR (ann.)
    -11.6%
    All-Time CAGR
    -13.1%

    Valuation

    PE Ratio
    -6.13
    Forward PE
    N/A
    PEG Ratio
    0.04
    Forward PEG
    -0.31
    PS Ratio
    32.83
    Forward PS
    19.80
    PB Ratio
    1.99
    P/FCF Ratio
    -5.56
    P/Adj. FCF Ratio
    -4.89
    P/OCF Ratio
    -7.26
    EV/Sales
    15.10
    EV/EBIT
    -3.48
    EV/EBITDA
    -3.53
    EV/FCF
    -2.56
    Earnings Yield
    -16.3%
    FCF Yield
    -18.0%
    Adj. FCF Yield
    -20.4%

    Financial Health

    Net Cash
    $324.58M
    Total Debt
    $5.7M
    Cash & Short-Term Investments
    $330.28M
    Total Assets
    $381.23M
    Current Ratio
    9.36
    Quick Ratio
    9.36
    Debt / Equity Ratio
    0.02
    Debt / EBITDA
    -0.07
    Debt / FCF
    -0.05
    OCF / Debt
    -18.93
    Interest Coverage
    0.00
    Altman Z-Score
    2.21
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    98.6%
    Operating Profit Margin
    -476.2%
    EBITDA Margin
    -427.4%
    Net Profit Margin
    -435.2%
    FCF Margin
    -590.3%
    Adj. FCF Margin
    -671.4%
    SBC / Revenue
    55.4%
    SBC Impact (per share)
    -13.8%

    Returns

    Return on Assets
    -20.9%
    Return on Equity
    -38.5%
    Return on Invested Capital
    -25.4%
    Return on Capital Employed
    -25.5%
    Return on Tangible Assets
    -21.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -38.7%
    Revenue CAGR 5Y
    -22.7%
    Revenue CAGR 10Y
    7.1%
    EPS CAGR 3Y
    -327.8%
    EPS CAGR 5Y
    86.0%
    EPS CAGR 10Y
    22.8%
    FCF CAGR 3Y
    -12.0%
    FCF CAGR 5Y
    3.8%
    FCF CAGR 10Y
    -26.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    21
    EPS Growth Next 3Y
    3.0%
    Revenue Growth Next 3Y
    43.8%
    Earnings Date
    N/A
    EPS Estimate (next Q)
    N/A
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $8.50
    Price Target Upside
    208.0%

    Cash Flow

    Operating Cash Flow
    $-107.96M
    Free Cash Flow
    $-108.03M
    Adj. Free Cash Flow
    $-122.88M
    FCF Per Share
    -$0.38
    OCF Per Share
    -$0.38
    OCF/S Ratio
    -450.3%

    Income Statement

    Revenue
    $18.3M
    Gross Profit
    $18.05M
    Operating Income
    $-87.15M
    EBITDA
    $-78.23M
    Net Income
    $-79.65M
    EPS (Diluted)
    -$0.45
    Revenue / Employee
    $265.25K
    Profit / Employee
    $-1.15M
    Employees
    69

    © 2026 bestshares.com. All rights reserved.